| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Reply to: Do current data justify the framing of respiratory fluoroquinolones and lascufloxacin in the 2024 JRS adult pneumonia guideline digest? |
| 掲載誌名 | 正式名：Respiratory investigation 略 称：Respir Investig ISSNコード：22125345/22125353 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 64(4),pp.101466 |
| 著者・共著者 | Hiroshi Mukae, Naoki Iwanaga, Nobuyuki Horita, Kosaku Komiya, Takaya Maruyama , Yuichiro Shindo, Yoshifumi Imamura, Kazuhiro Yatera, Yoshihiro Yamamoto, Katsunori Yanagihara, Nobuaki Shime, Kazuyoshi Senda, Hiroshi Takahashi, Futoshi Higa, Tetsuya Matsumoto, Makoto Miki, Shinji Teramoto, Hiroki Tsukada, Masahiro Yoshida, Naoyuki Miyashita ; members of the systematic review team of the Japanese Respiratory Society for the Japanese Clinical Practice Guidelines for Pneumonia in Adults 2024 |
| 発行年月 | 2026/06 |
| DOI | 10.1016/j.resinv.2026.101466 |
| PMID | 42314621 |